In 2011 the FDA approved a tumor-treating fields device for the treatment of certain tumors including glioblastoma multiforme (GBM), the most aggressive brain tumor. In one study, patients who had recurrent GBM and who underwent TT fields treatment saw improvement in survival comparable to that of a second round of chemotherapy.